2024年會議議程
2024年3月26-27日
2024年會議議程
三十年來，Precision Med TRI-CON 一直是診斷和精準醫學界至關重要的國際會議場所。歷年來均與數千名國際思想領袖一起討論實施精準醫學、生物標記和伴隨診斷、基因組醫學和精準健康的最新研究、技術、創新和商業模式；傳染病的家庭診斷、護理點檢測和分子診斷的創新和市場進入策略；液體活檢和精準腫瘤學的先進診斷，包括多癌早期檢測和微小殘留疾病檢測。而2024年的會議更將涵蓋更快、更便宜的測序、人工智慧和數位工具以及空間生物學和單細胞多組學對推進精準醫學的新興影響。一起來到陽光明媚的聖地牙哥加入我們吧！TRI-CON將會安排各種現場交流和富有遠見且發人深省的主題演講等您所期待的各種會議活動。
2024年主講人
FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine
爐邊談話：精準醫療上的人工智慧創新
Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research
Interviewed by: Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University
Kari Stefansson
CEO
deCODE genetics
Mara Aspinall
Partner
Illumina Ventures
Anthony Sireci
SVP, Diagnostics Development, Loxo Oncology
Eli Lilly
Atul Butte
Chief Data Scientist
University of California Health
Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health
Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center
Jeffrey Venstrom
CMO
GRAIL
Razelle Kurzrock
CMO
Worldwide Innovative Network for Personalized Cancer Therapy
Jonathan Carlson
Managing Director
Microsoft Health Futures
Sonya Makhni
Medical Director
Mayo Clinic Platform
Ezra Cohen
CMO, Oncology
Tempus Labs
Howard Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center
Jean-Francois Martini
Diagnostics Lead, Oncology
Pfizer
Lourdes Barrera
Executive Director, Precision Medicine
Merck
Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS
Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi
George Vacek
Global Head, Genomics Alliances
NVIDIA
Larissa May
Director, Emergency Medicine Innovation
UC Davis Health
Peter Bach
CMO
Delfi Diagnostics
Anne Beaubrun
VP, Global Health Economics & Outcomes
Cepheid
Yuan Luo
Chief AI Officer, Northwestern Univ.
Feinberg School of Medicine
John Mattison
Chief Medical Information Officer
Arsenal Capital Partners
Jennifer Quigley
Sr. Director, Precision Diagnostics
Novartis
Scott Penberthy
Managing Director, Applied AI
Google Cloud
Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI
Edward Abrahams
President
Personalized Medicine Coalition
Jonathan Beer
Sr. Director, Diagnostic Science
Bristol Myers Squibb
Jim Almas
VP, Clinical Effectiveness
LabCorp
Stacey DaCosta Byfield
VP, Genomic Health Economics and Outcomes
Optum Labs
Larry Kessler
Co-Chair
MCED Consortium
Noah Zimmerman
VP, Translational Science
Tempus
Mark Gardner
SVP, Molecular Genomics
Quest Diagnostics
Lesley Northrop
Chief Diagnostic Officer
Everly Health
Charles Chiu
Director, Clinical Microbiology Laboratory
UCSF
Christopher Conn
Director, Diagnostics Strategy
Amgen
TRI-CON 2023 盛況
